PMEF
SEM

Point72 Middle East FZE’s Select Medical SEM Stock Holding History

Point72 Middle East FZE’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,976
Closed -$304K – 1106
2023
Q4 		$304K Sell
23,976
-23,007
-49% -$290K 0.01% 956
2023
Q3 		$640K Buy
46,983
+23,746
+102% +$367K 0.02% 727
2023
Q2 		$399K Buy
+23,237
New +$360K 0.01% 845

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Point72 Middle East FZE's SEM Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Select Medical (SEM) in Q1 2024, closing a stake of 23,976 shares — an estimated $304K sold.

Point72 Middle East FZE first reported a position in SEM in Q2 2023 and held it in 3 quarters. The position peaked at $640K in Q3 2023. 250 funds tracked by Wall St. Rank hold SEM as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Select Medical position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 23,976 Select Medical shares in Q1 2024, an estimated $304K.
  • Point72 Middle East FZE first reported a position in Select Medical in Q2 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's Select Medical position peaked at $640K in Q3 2023.
  • 250 funds tracked by Wall St. Rank held Select Medical as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.